Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jack

Showing results (451-460 of 594) with videos related to

Pageof 60
Sort By:
Cancer Research|May 20, 2016
Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center StudyJennifer J Wheler, Filip Janku, Aung Naing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group StudyAnita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Journal of the National Cancer Institute|April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patientsFadlo R Khuri, J Jack Lee, Scott M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Fenretinide activity in retinoid-resistant oral leukoplakiaScott M Lippman, J Jack Lee, Jack W Martin, et al.
JAMA Network Open|June 6, 2022
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative DurvalumabYufei Liu, Zhe Zhang, Waree Rinsurongkawong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancerF Christopher Holsinger, Merrill S Kies, Eduardo M Diaz, et al.
Clinical Lung Cancer|June 11, 2014
Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusionErminia Massarelli, Amir Onn, Edith M Marom, et al.
Plos One|July 7, 2011
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cellsYun-Ju Chen, Wei-Chien Huang, Ya-Ling Wei, et al.
Cancer Research|July 5, 2011
Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapyFei Yang, Ximing Tang, Erick Riquelme, et al.
Advances in Therapy|July 9, 2021
Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II TrialRenata Ferrarotto, Luana G Sousa, Yun Qing, et al.
Pageof 60

Showing results (451-460 of 594) with videos related to

Sort By:
Pageof 60
Cancer Research|May 20, 2016
Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center StudyJennifer J Wheler, Filip Janku, Aung Naing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group StudyAnita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Journal of the National Cancer Institute|April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patientsFadlo R Khuri, J Jack Lee, Scott M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Fenretinide activity in retinoid-resistant oral leukoplakiaScott M Lippman, J Jack Lee, Jack W Martin, et al.
JAMA Network Open|June 6, 2022
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative DurvalumabYufei Liu, Zhe Zhang, Waree Rinsurongkawong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancerF Christopher Holsinger, Merrill S Kies, Eduardo M Diaz, et al.
Clinical Lung Cancer|June 11, 2014
Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusionErminia Massarelli, Amir Onn, Edith M Marom, et al.
Plos One|July 7, 2011
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cellsYun-Ju Chen, Wei-Chien Huang, Ya-Ling Wei, et al.
Cancer Research|July 5, 2011
Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapyFei Yang, Ximing Tang, Erick Riquelme, et al.
Advances in Therapy|July 9, 2021
Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II TrialRenata Ferrarotto, Luana G Sousa, Yun Qing, et al.
Pageof 60